1. Home
  2. RGEN vs RHP Comparison

RGEN vs RHP Comparison

Compare RGEN & RHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • RHP
  • Stock Information
  • Founded
  • RGEN 1981
  • RHP 1991
  • Country
  • RGEN United States
  • RHP United States
  • Employees
  • RGEN N/A
  • RHP N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • RHP Real Estate Investment Trusts
  • Sector
  • RGEN Health Care
  • RHP Real Estate
  • Exchange
  • RGEN Nasdaq
  • RHP Nasdaq
  • Market Cap
  • RGEN 6.5B
  • RHP 6.1B
  • IPO Year
  • RGEN N/A
  • RHP 1991
  • Fundamental
  • Price
  • RGEN $124.56
  • RHP $100.77
  • Analyst Decision
  • RGEN Buy
  • RHP Buy
  • Analyst Count
  • RGEN 9
  • RHP 10
  • Target Price
  • RGEN $167.38
  • RHP $113.50
  • AVG Volume (30 Days)
  • RGEN 663.7K
  • RHP 533.5K
  • Earning Date
  • RGEN 07-29-2025
  • RHP 11-03-2025
  • Dividend Yield
  • RGEN N/A
  • RHP 4.57%
  • EPS Growth
  • RGEN N/A
  • RHP N/A
  • EPS
  • RGEN N/A
  • RHP 4.20
  • Revenue
  • RGEN $673,956,000.00
  • RHP $2,444,417,000.00
  • Revenue This Year
  • RGEN $16.74
  • RHP $9.21
  • Revenue Next Year
  • RGEN $13.86
  • RHP $7.95
  • P/E Ratio
  • RGEN N/A
  • RHP $24.00
  • Revenue Growth
  • RGEN 8.73
  • RHP 6.21
  • 52 Week Low
  • RGEN $102.97
  • RHP $76.27
  • 52 Week High
  • RGEN $182.52
  • RHP $121.77
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 54.93
  • RHP 60.69
  • Support Level
  • RGEN $112.71
  • RHP $96.62
  • Resistance Level
  • RGEN $124.91
  • RHP $99.98
  • Average True Range (ATR)
  • RGEN 4.32
  • RHP 1.88
  • MACD
  • RGEN 0.11
  • RHP 0.64
  • Stochastic Oscillator
  • RGEN 80.23
  • RHP 80.97

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About RHP Ryman Hospitality Properties Inc. (REIT)

Ryman Hospitality Properties Inc is a lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and country music entertainment experiences. Its core holdings are Gaylord Opryland Resort & Convention Center; Gaylord Palms Resort & Convention Center; Gaylord Texan Resort & Convention Center; Gaylord National Resort & Convention Center; and Gaylord Rockies Resort & Convention Center. The company has three business segments: Hospitality, which includes Gaylord Hotels properties, the Inn at Opryland, and the AC Hotel, Entertainment which includes the entertainment and media assets comprising OEG, and Corporate and Other, which includes corporate expenses. It derives the vast majority of its revenue from its Hospitality segment.

Share on Social Networks: